Over 20,000 business participants

Company Information

Company Takeda Pharmaceuticals International AG
www.takeda.com
Type:
Company
Country:
Switzerland
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
08 January 2024
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2026

Engagements

Parent Company

Country Company Name
Japan Takeda Pharmaceutical Company Limited

Forward Faster

Gender Equality
Sign-on Date Due Date
Climate Action
Sign-on Date Due Date

Set corporate science-based net-zero emissions targets in line with a 1.5°C pathway, with the goal of halving global emissions by 2030 and reaching net-zero by 2050 at the latest.

18-Dec-2024
Living Wage
Sign-on Date Due Date
Water Resilience
Sign-on Date Due Date
Finance & Investment
Sign-on Date Due Date


Parent Communication On Progress

Published On Title Level/Status
22-Jul-2025 2025 Communication on Progress Submitted
23-Jul-2024 2024 Communication on Progress Submitted
16-Dec-2022 2022 Annual Integrated Report Active
20-Dec-2021 2021 Annual Integrated Report Learner
25-Dec-2020 2020 Sustainability Report Active
14-Jan-2020 Sustainable Value Report 2019 Active
31-Jul-2019 Grace Letter Not applicable
30-Oct-2018 Sustainable Value Report 2018 Advanced
30-Oct-2017 Sustainable Value Report 2017 Advanced
31-Oct-2016 Communication on Progress Advanced
02-Nov-2015 Communication on Progress Advanced
04-Nov-2014 Communication on Progress Advanced
10-Nov-2013 Communication on Progress Advanced
09-Nov-2012 Communication on Progress Advanced
08-Dec-2011 Annual Report 2011/ CSR Databook 2011 Advanced
08-Dec-2010 2010 Communication on Progress Not applicable
08-Dec-2009 2009 CSR Databook Not applicable